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Background: Endovascular graft designs incorporating sidebranches, fenestrations and scallops offer
a minimally-invasive alternative to open surgery and hybrid approaches for thoracoabdominal aortic
aneurysms (TAAA). Our unit has offered total endovascular TAAA repair to selected higher-risk patients
since 2008. We report the largest UK series to date of total endovascular TAAA repair.
Methods: Retrospective analysis of a prospectively-maintained operative database.
Results: 31 patients (21 male, 10 female) median age 71 years (range 58e84), with TAAA (12 Crawford
type I, 13 type III, 6 type IV), median diameter 6.4 (4.3 (mycotic)- 9.9) underwent endovascular TAAA
repair (total 48 sidebranches, 26 fenestrations, 13 scallops) between July 2008 and January 2011. Median
operating time 225 min (65e540 min), X-ray screening time 58 min (4e212 min), contrast dose 175 ml
(70e500 ml), blood loss 325 ml (100e400 ml). Median post-operative length of hospital stay 6 days (2
e22 days). Three patients (3/31, 9.7%) died within 30 days of operation: multisystem organ failure (1)
acute renal failure and paraplegia (1) and paraplegia (1). There were no other cases of in-hospital organ
failure, paraplegia or major complications. The median change in pre-discharge from pre-operative renal
function was 3.4% deterioration in eGFR (range: 32.7% deterioration to 73.0% improvement) One patient
presented with late-onset paraparesis, a second developed acute renal failure 8 months after repair. One
early high-pressure endoleak (type 3) required correction. Three patients had died by median follow-up
12 months (1e36), 2 from heart disease and one from haemopericardium secondary to acute dissection
of the ascending aorta (the dissection did not involve, nor extend close to, the endovascular graft).
Conclusions: Total endovascular repair of TAAA offers patients a minimally-invasive alternative to open
surgery with early results at least comparable to those seen with open or hybrid surgical approaches.
 2011 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Introduction
Aortic aneurysms involving the thoracoabdominal segment of
the aorta present a considerable technical challenge. As well as the
difﬁculties of surgical access, the involvement of the coeliac,
superior mesenteric and renal arteries requires special attention to
minimise ischaemia and reperfusion injury. The poor tolerance of
the liver, gut and kidneys to prolonged ischaemia accounts for
much of themortality of aortic repairs in this territory. Compromise
of important spinal intercostal arteries and the consequent risk of
paraplegia further increases the morbidity associated with surgery.
Over the last four decades, open surgical strategies, such as
‘clamp-and-go’ and partial left heart bypass with selective visceralf Vascular Surgery, Guy’s and
dge Road, London SE1 7EH,
gh).
ciety for Vascular Surgery. Publisheperfusion, have evolved to address these risks. Despite these
developments the mortality and morbidity associated with exten-
sive open thoracoabdominal aortic aneurysm (TAAA) surgery
remains as high as 20%, increasing up to 40% in high-risk groups,
and carries a signiﬁcant additional risk of paraplegia.1e3 In high-
risk groups, it may be better to leave the aneurysm untreated and
accept the risk of rupture.
Endovascular surgery offers a less invasive alternative to open
surgery for the prevalent forms of infrarenal abdominal (‘AAA’) and
descending thoracic aortic (TAA) aneurysms, with a lower peri-
operative morbidity and mortality.4,5 The ‘hybrid’ strategy uses
extra-anatomic retrograde bypass of the visceral vessels in order to
debranch the aorta and thereby allow the aneurysm to be relined
with tubular stent grafts. This hybrid open-endovascular strategy
reduces the total ischaemic insult associated with standard open
surgical techniques, but remains a complex surgical procedurewith
a signiﬁcant mortality (15%) and morbidity.6e8
Total endovascular repair of thoracoabdominal aortic aneu-
rysms can be performed using custom-made endovascular graftsd by Elsevier Ltd. All rights reserved.
Table 1
Patient demographics and aneurysmmorphology. [Chronic renal failurewas deﬁned
as estimated glomerular ﬁltration rate (eGFR) < 60 ml/min/1.73 m2. Other major co-
morbidities included for example, pneumonectomy for tuberculosis or sternotomy
for cardiac surgery.]
Variable
Patient demographics Median age (range) 71 (58e84)
Male gender (%) 21/31 (67.7)
Cormobidities ASA grade III or higher (%) 31/31 (100)
Hypertension (%) 25/31 (80.6)
Coronary artery disease (%) 10/31 (32.3)
Cardiac arythmia (%) 7/31 (22.6)
Diabetes mellitus (%) 2/31 (6.5)
Chronic obstructive
pulmonary disease (%)
5/31 (16.1)
Chronic renal failure (%) 14/31 (45.1)
Previous aortic surgery (%) 6/31 (19.4)
Connective tissue disease (%) 0/31 (0)
Other major comorbidity (%) 8/31 (25.8)
Aneurysm
characteristics
Crawford type I (%) 12/31 (38.7)
Crawford type II (%) 0/31 (0)
Crawford type III (%) 13/31 (41.9)
Crawford type IV (%) 6/31 (19.4)
Median maximal aortic
diameter/cm (range)
6.4 (4.3e9.9)
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preserve blood ﬂow to visceral and renal vessels while excluding
the aneurysm from the circulation.9,10 Several series from the US
and continental Europe have reported favourable results with these
techniques and an early UK series of six patients was reported in
2008.9e15
We have performed total endovascular repair to selected high
surgical-risk patients since 2008. We report the largest UK series to
date, examine the results and discuss what the future may hold for
this technology.
Methods
All patients with aortic aneurysms, not treated as an emergency,
were discussed in a multidisciplinary meeting involving vascular
surgeons, radiologists and, in the case of supradiaphragmatic
aneurysms, cardiac surgeons. Patients considered suitable candi-
dates for open surgery underwent aortic repair using partial left
heart bypass, selective visceral perfusion and inlay grafting (for
Crawford type I, II, III TAAA) (n¼ 15) or supracoeliac ‘clamp-and-go’
for type IV TAAA (n ¼ 4).
Thirty-six patients who underwent fenestrated endovascular
repair during this period for juxtarenal aortic aneurysms that could
have been repaired at open surgery using a suprarenal aortic clamp
(i.e. not thoracoabdominal aortic aneurysms) were excluded from
the analysis.
Written informed consent was obtained from all patients. Pre-
operative assessment included physical examination and routine
blood tests, trans-thoracic echocardiography, pulmonary function
testing, cardiac stress test and selective coronary angiography.
Patients considered at high risk for open surgery, due to comor-
bidity or previous surgery, were assessed with a view to anatomical
suitability for total endovascular repair.16 If considered feasible and
justiﬁed in terms of risks, detailed custom-made graft (Cook
Medical, Brisbane, Australia) design was planned using 3D multi-
slice computed tomography (CT) scans with centreline-of-ﬂow
reconstruction (iNtuition, TeraRecon, Foster City, CA).
Three patients were declined complex endovascular repair
because of anticipated anatomical difﬁculties (angulation, ostial
stenoses, narrow aortic lumen). In addition, three patients chose to
decline repair after counselling on the risks and beneﬁts.
Endovascular grafts were introduced through the femoral artery
or iliac conduit access (2 patients) and bridging covered stents
placed via a contralateral femoral sheath (for fenestrated designs)
or via the left axillary artery for sidebranch designs. A spinal drain
was positioned pre-operatively in all patients. Cerebrospinal ﬂuid
was drained if the patient developed symptoms of paraplegia or
paraparesis. Patients were followed up by computed tomography
(CT) angiography at 3 months and review in the clinic at 4 months.
CT angiography and clinical review were performed annually
thereafter.
All endovascular procedures were recorded on a prospectively-
maintained database which records operation time, blood loss, X-
ray screening time, iodinated contrast use, post-operative renal
function, patient outcome, length of stay and complications.
Results
Patient details
Between July 2008 and January 2011, 31 patients (21 male, 10
female) with a median age of 71 years (range 58e84) underwent
total endovascular repair of thoracoabdominal aortic aneurysms
(Table 1). There were no conversions to open repair. One patient
was operated for dissection, six patients had previously undergoneaortic surgery and ﬁve thoracoabdominal surgery. No patients were
known to have connective tissue disease. Twelve patients had
Crawford type I TAAA, 13 patients had a type III TAAA, and 6
patients had a type IV TAAA (Fig.1). No type II TAAAwas referred for
consideration for endovascular repair during this series. The
requirement of landing zones to seal at the proximal and distal ends
of the aneurysm effectively extends the repair beyond the aneu-
rysm and could be used to ‘upgrade’ the complexity, but we have
classiﬁed according to the extent of the aneurysm extent rather
than the extent of the repair. Median aneurysm diameter was
6.4 cm (range 4.3e9.9): the 4.3 cm aneurysmwas a proven mycotic
aneurysm, treated with adjunctive antibiotics and continues to
remain clinically and radiologically free of infection 18months after
aortic repair. Pre-operative renal function showed a median esti-
mated glomerular ﬁltration rate (eGFR) of 58 ml/min (range
29e194 ml/min).
Endovascular graft design
Device designs varied according to the extent of the aneurysm,
vessels involved in the landing zones and the number, size and
patency of visceral vessels. Complexity ranged from a single scallop
to preserve coeliac artery ﬂow in a type I TAAA (8 patients) through
more complex branched cases (either internal/external sidebranch
design or fenestrated branches, with or without additional scal-
lops): 1 branch (1 patient), 2 branches (3 patients), 3 branches (9
patients) or 4 branches (10 patients), incorporating a total of 48
internal-external sidebranches, 26 fenestrations and 13 scallops. All
internal-external sidebranches were bridged into the target vessel
ostia with covered stents (Fluency stent-graft, CR Bard Inc, Karls-
ruhe, Germany), reinforced with uncovered self-expanding stents
(Zilver, Cook Medical, Bloomington, In, US) and all fenestrations
were bridged into target vessel ostia using balloon-expandable
covered stents (Advanta V12, Atrium Medical Corp. NH, USA).
Twenty-two of the grafts were tubes, 9 were bifurcated into the
iliac arteries.
Procedural details
The median time between presentation to our unit and
operative repair was eight weeks (range 4e12). Nineteen of the
procedures were performed under general anaesthesia, 11 under
Figure 1. Crawford classiﬁcation of thoracoabdominal aortic aneurysms. In this article, we have deﬁned the repair by the extent of the aneurysm. The need for proximal and distal
landing zones in endovascular repair can lead to ‘upgrading’ of the aneurysm if classiﬁed by the extent of the repair.
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One patient required an iliac conduit for access. Endovascular
grafts were positioned and branches cannulated using X-ray
ﬂuoroscopic guidance (Fig. 2). The median operating time was
225 min (range 65e540), ﬂuoroscopic X-ray screening time
58 min (range 4e212 min), iodinated contrast dose 175 ml (range
70e500 ml) and median estimated blood loss was 325 ml (range
100e4000). Median post-operative length of stay was 6 days
(range 2e22). Completion angiography conﬁrmed patency of allFigure 2. Intraoperative X-ray ﬂuoroscopy image during endovascular repair of a type
III TAAA. Four branches, each composed of a covered stent lined with an uncovered
stent, are needed to bridge the gap between the graft sidebranches (identiﬁed by 3
proximal and 2 distal radio-opaque markers) and the target vessels.target vessels, although one renal artery could not be secured as
outlined below.
Clinical outcomes
In-hospital mortality
Three patients (9.7%) died within 30 days of operation (Table 2).
One 83 year-old female patient undergoing repair of a type I TAAA
using a single distal (coeliac) scallop had rupture of a narrow iliac
artery and massive haemorrhage (4000 ml). This was repaired with
oversew of the iliac artery and femorofemoral crossover graft. The
patient developed multisystem organ failure and died on the
intensive therapy unit (ITU) 22 days later. Another patient, a 77
year-old male, underwent a technically successful 4 branched
repair of a type IV TAAA but developed massive microembolisation
(noticed immediately post-operatively) affecting the abdominal
wall and lower limbs. He developed acute renal failure and para-
plegia and died on ITU 6 days post-operatively. The third fatality
was an 84 year-old female with a type IV TAAA and single renal
artery. A bifurcated device with 2 branches (SMA/left renal artery)
was used but the renal artery could not be secured with a bridging
stent. The patient developed a large posterior circulation stroke
(probably related to prolonged manipulations though the leftTable 2
Post-operative complications.
Variable Number Series %
Death 3 9.7
Iliac artery injury 1 3.2
Paraparesis 1 3.2
Paraplegia 2 6.5
Stroke 1 3.2
Transient dialysis 2 6.5
Permanent dialysis 1 3.2
Multisystem organ failure 1 3.2
Endoleak
Type II 2 6.5
Type III 1 3.2
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renal failure. After palliative care was initiated 14 days later on the
ITU, she became hypotensive, developed paraplegia and died on the
17th post-operative day.
In-hospital complications
There were no other cases of organ failure, paraplegia or major
in-hospital complications. No other patient stayed longer than 24 h
on the post-operative ITU. The median change in pre-discharge
from pre-operative renal function was a 3.4% deterioration in the
eGFR (2 ml/min), range 32.7% deterioration (28 ml/min) to 73.0%
(43 ml/min) improvement. Fourteen patients had a change in eGFR
of 10% or less, 10 patients had an improvement >10%, 7 had
a deterioration of >10%.
Late complications
Patients had a post-operative CT scan at 3 months post-
discharge (Fig. 3). Endoleak was identiﬁed in three patients: type
II in two patients and type III in one patient. The type II endoleaks
were not associated with sac enlargement and no secondary
procedures have been performed. The type III endoleak, originating
from a coeliac bridging stent, was identiﬁed on the ﬁrst follow-up
scan and is currently undergoing further assessment with a view
to treatment.
One 65 year-old male patient with a type III TAAA (treated using
a tube device with 4 branches), presented 4 weeks after discharge
with new onset paraparesis, consisting of bladder and bowel
sphincteric symptoms and unilateral lower limb weakness with
decreased sensation. Blood pressure manipulation and cerebro-
spinal ﬂuid drainage had little effect. His recovery continues to be
monitored as an outpatient: after 9 months, he remains ambulant
and not requiring a urinary catheter although still symptomatic in
the lower limb and sphincters.
One patient, a 62 year-old malewith a type III TAAA treated with
a bifurcated device with 3 branches (SMA/LRA/RRA), presented 7
months later with acute renal failure related to kinking of both
renal bridging stents. A follow-up scan at 3 months had been
satisfactory. Despite salvage angioplasty and re-stenting, he
remains on dialysis although passing signiﬁcant volumes of urine.Figure 3. Three month follow-up CT scan of the same patient as in Fig. 2, showing
contrast enhancement in the aorta and iliac arteries and preservation of blood ﬂow in
all 4 branches (coeliac artery, superior mesenteric, left and right renal arteries). No
contrast is seen in the aneurysm sac (not visible), conﬁrming successful exclusion of
the aneurysm.Follow-up
Patients remain on long-term annual CT surveillance as the
durability and long-term complications of this technology is not yet
known. Median follow-up in our series is 12 months, range 1e36
months. No patients were lost to follow-up. Three further patients
have died during the follow-up period: two from conﬁrmed cardiac
related causes (one at 3 months (82 year-old female, type I TAAA,
distal scallop to coeliac artery), one at 28months (78 year-old male,
type III TAAA, tube device with 3 branches (SMA/LRA/RRA)) post-
operation); and one at 2 months from haemopericardium
secondary to acute dissection of the ascending aorta. This last
patient was a 69 year-old female who was known to have a 5.4 cm
ascending aortic aneurysm but had been declined repair pending
repair of the 6.4 cm type I TAAA. Post-mortem examination
conﬁrmed acute Stanford type A dissection, originating in a 2 cm
intimal tear 3 cm above the aortic valve. The dissection did not
involve, nor extend close to, the endovascular graft which had
remained patent in all 4 branches.
Discussion
Total endovascular repair of thoracoabdominal aortic aneu-
rysms is technically feasible and can offer patients an alternative to
open or hybrid repair strategies. This is the largest reported series
from the UK to date and has a mortality of 9.7% and a similar rate of
major complications during follow-up. These ﬁgures correlate well
with the results reported in the other large international series, and
suggest that this technology is transferable to centres with appro-
priate expertise.11e14
To date, we have reserved this procedure for patients considered
high risk for open surgery, either because of comorbidity or
previous surgery. However the results in this high-risk cohort
compare favourably with many series in the literature of open and
hybrid TAAA repair, as well as our own published open
series.3,7,8,17e19 We have treated 109 patients with Crawford type I
to IV thoracoabdominal aortic aneurysms with open surgical repair
over a 16-year period. The combined mortality for TAAA type IeIV
treated using surgical adjuncts was 14.1% (type IeII 17.1%; type IV
10.8%) and the paraplegia ratewas 7.7% (type IeII 14.6%; type IV 0%).
We anticipate that with continued experience we will expand the
indications to include a lower risk group of patients who may
beneﬁt from total endovascular TAAA repair.
Anatomical considerations play a major role in case selection
andwe acknowledge that some patients whomight otherwise have
been offered endovascular repair have been declined due to
anticipated difﬁculties with aortic tortuosity and visceral and renal
arterial disease. Over the course of our experience, we have
widened the anatomical indications but there are still some
anatomical obstacles to endovascular repair, including excessive
tortuosity, diseased target vessel ostia and difﬁcult aortic arch
conformations.
Eight type 1 TAAAs were treated by scalloped thoracic stent
grafts and 4 were treated by fenestrated or true branched grafts.
There was a very ﬁne (a matter of millimetres) distinction between
aneurysms treated with a scalloped TAA device and a distal
fenestrated TAA device. Early in our experience, we erred on the
side of simplicity of repair, in that if the aortic diameter was below
40mm at the level of the coeliac artery wewould prefer a scalloped
device even if the true aneurysm ﬁnished at a lower level. Later,
with increased conﬁdence and having seen distal endoleak with
this approach, we tended to favour distal fenestrated devices. We
justify including the scalloped grafts in this series as the open
surgical option would have required full thoracoabdominal repair.
In addition, although the procedural complexity was reduced, this
sub-group (n ¼ 8) accounts for one early death (12.5%), one late
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does not ﬂatter, and adds to the overall results.
Women are known to have smaller diameter blood vessels and
this can cause problems with access as well as difﬁculty cannulat-
ing target vessels. Two of the early deaths in this series occurred in
women; one associated with iliac artery injury and the other with
difﬁculty securing a bridging stent in the renal artery. Some series
in the literature have shown higher rates of endoleak and conver-
sion to open repair in women but this is not borne out in larger
series.20,21
Further advances in graft design and navigational techniques
such as image-guided surgery and robotics may be necessary
before all patients who might otherwise be treated with open
surgery could be considered anatomically suitable for endovascular
repair.
Device design is constantly evolving and off-the-shelf endo-
vascular grafts suitable for a large proportion of patients with TAAA
have been proposed. The stents currently used for branches were
originally designed for other applications and the kinking of self-
expanding covered stents (despite being reinforced with uncov-
ered stents) led to one patient in this series requiring dialysis.
Stents designed speciﬁcally for this application may prevent these
complications in future.
The desire for strong, robust endovascular grafts must be
balanced against the need to have devices that can be introduced
through diseased femoral and iliac arteries and track around aor-
toiliac tortuosity. Rupture of an iliac artery led to one of the patient
deaths in our series and we advocate the use of adjunctive access
procedures, such as conduits, to minimise these risks in patients
with narrow iliac vessels.
Spinal cord injury is a signiﬁcant complication of both open and
endovascular thoracoabdominal aortic aneurysm repair. The
complication is reported to occur in 4e11% of cases undergoing
open repair and 0e16.7% of patients undergoing endovascular
repair.1,12,13,22,23 In our series, three patients developed symptoms
of spinal cord injury (3/31, 9.7%). The mechanism of injury in each
case appears to be different, ranging from embolic debris, to
systemic hypo-perfusion and (presumably) late thrombosis of small
feeding vessels with low ﬂow. The aetiology of spinal cord injury
following aortic intervention is complex, and despite advances in
imaging technology it is still not well understood. Perfusion
branches are recent developments which have been introduced to
try to reduce the incidence of paraplegia. However, the only patient
in our series left disabled because of spinal cord ischaemia, had
a late onset of his symptoms and it is not clear that a perfusion
branch might have offered any protection.
Although this is one of the largest series reported, it remains
a relatively small single centre experience, designed to demon-
strate that this technology is transferrable to centres with appro-
priate expertise. Our centre ﬁrst offered total endovascular repair
for thoracoabdominal aortic aneurysms in 2008 and so the data in
this manuscript also reﬂects our learning curve experience. It is
therefore likely that as we accumulate more experience the results
will improve. The patients evaluated in this series were considered
unﬁt for open surgical repair and this technology therefore rep-
resented their only treatment option. Our results are encouraging
when evaluated in light of the results of published series of
open surgical and hybrid repair. It is reasonable to speculate that
if high-risk patients treated with total endovascular repair
have similar results to ﬁt patients with open repair, that in future
lower risk patients may gain additional beneﬁt from total endo-
vascular repair.
Total endovascular repair of thoracoabdominal aortic aneu-
rysms is a technically demanding procedure that currently requires
careful case selection and meticulous planning combined witha team familiar with the intricacies of the technique. However the
procedure can offer a truly minimally-invasive alternative to open
thoracoabdominal aortic aneurysm surgery, or hybrid approaches,
with at least comparable perioperative morbidity and mortality to
results reported in the literature. We believe that the indications
and applicability of the technique will continue to expand in
parallel with evolutions in graft design and endovascular surgical
technology.
Conclusions
Minimally-invasive, total endovascular repair of thor-
acoabdominal aortic aneurysms can offer patients an alternative to
open surgery with early results at least comparable to those re-
ported in the literature for more invasive procedures. Evolving
device technology and advances in endovascular surgical tech-
niques make it likely that the indications or this procedure will
continue to expand. Long-term durability is still largely unknown
and careful follow-up and reporting is advised.
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